Count Me In: Partnering with Patients to Define the Landscape of Rare, Aggressive Sarcomas
Attend this seminar to discover how the nonprofit research initiative “Count Me In” is partnering researchers with patients to understand rare, aggressive cancers. Harvard Medical School’s Dr. Katherine Janeway will elaborate on the initiative’s particular work with osteosarcoma and leiomyosarcoma.
The Cancer MoonshotSM Seminar Series showcases the research progress of different Cancer Moonshot initiatives.
The Cancer Moonshot Blue Ribbon Panel of scientific experts created a report outlining 10 recommendations. These recommendations are meant to accelerate progress in cancer prevention, diagnosis, and treatment.
Dr. Janeway is an associate professor of pediatrics at Harvard Medical School and a senior physician of pediatric oncology at Dana-Farber Cancer Institute.
Upcoming Events
- Predicting Patients’ Response to Immunotherapy from Tumor Histopathology and Blood: Computational Science in Immuno-oncologyJuly 08, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025Childhood Cancer Data Initiative (CCDI) Symposium 2025October 06, 2025 - October 07, 2025